Supracondylar Post-Operative Pain Study
Supracondylar Humerus Fracture
About this trial
This is an interventional treatment trial for Supracondylar Humerus Fracture focused on measuring closed reduction percutaneous pinning, post-operative pain control, opiod, pediatric, elbow fracture
Eligibility Criteria
Inclusion Criteria:
- Closed supracondylar humerus fracture
- Isolated supracondylar humerus fracture
- Type II and III supracondylar humerus fracture
- Fracutres treated with closed reduction percutaneous pinning
Exclusion Criteria:
- Fractures with concomitant vascular injury
- Fractures with concomitant neurologic deficit
- Pathologic fractures
- Fractures with concomitant injuries (multiple trauma)
- Fractures with swelling requiring post-operative hospitalization for monitoring
- Known history of allergies to acetaminophen, ibuprofen or oxycodone
- Patients with developmental delay that would preclude participation in the visual analog Faces Pain Scale-Revised
- Patients with intellectual disability that would preclude participation in the visual analog Faces Pain Scale-Revised
- History of suspected child abuse
Sites / Locations
- Orthopaedic Institute for ChildrenRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Ibuprofen
Oxycodone
This group is given acetaminophen (liquid oral medication, 15mg/kg/dose every 6 hours as needed, max 90mg/kg/day) as the first-line pain medication, and as needed ibuprofen for breakthrough pain (liquid oral medication, 10mg/kg/dose every 8 hours as needed, max dose 40mg/kg/day).
This group is given acetaminophen (liquid oral medication, 15mg/kg/dose every 6 hours as needed, max 90mg/kg/day) as the first-line pain medication, and as needed oxycodone for breakthrough pain (liquid oral medication, 0.1mg/kg/dose every 6 hours as needed).